The aim of this paper is a critical reflection of the practice in competitive cycling
to use the hematocrit value (Hct) as an indirect control measure for doping with erythropoietin.
To demonstrate the individual physiological variation of Hct values, five different
studies were performed: 1. Eight subjects were observed (i) during 23 h after a 1 h
lasting bout of cycle exercise at 60 % of maximum performance and (ii) during 24 h
under control conditions. 2. Seven subjects were exposed to a 20 min period of -7
° head down tilt (HDT), which was followed by 15 min in sitting position. 3. From
four subjects blood samples were taken in a sitting position up to 60 min after they
had ingested 1 liter isotonic saline solution. 4. Ten subjects performed a vita maxima
test on a cycle ergometer, starting at 100 W and increasing the workload by 17 W every
minute. 5. Four elite cyclists participated in a 10 days competition (1700 km).
Results: 1. During the 24 h observation period Hct decreased during the night from 45.3 ± 3.1
% to 42.9 ± 1.5 % and returned to the initial values in the morning. This diurnal
variation was even more pronounced after submaximal exercise (−4.1 %). 2. Due to fluid
shifts from the interstitial into the intravasal compartment, HDT was accompanied
by a 3.1 ± 0.5 % lower Hct. 3. Drinking of the isotonic saline solution also reduced
the hematocrit by 3.3 ± 0.5 % after one hour. 4. Maximum cycle exercise increased
the Hct from 46.8 ± 2.4 % to 51.3 ± 1.9 % which was due to a 15 % decrease in plasma
volume. 5. Repeated bouts of cycle-exercise reduced the Hct from 46.4 ± 1.5 % to 41.3 ± 1.6
%.
Conclusions: All experiments demonstrate that the Hct is not a constant value but can be considerably
changed by physiological measures. Clinical studies show that brain oxygen supply
decreases with increasing Hct-values, which are also associated with a higher risk
of stroke accidents. We therefore recommend to use a Hct-limit solely under strongly
controlled standardized conditions to protect professional cyclists from hazardous
manoeuvre until more appropriate methods to detect EPO-doping are developed.
Key words:
EPO - doping - plasma volume - exercise - diurnal changes - head down tilt - saline
References
- 1
Anthony A J.
Der Einfluß kurzdauernder Sauerstoffatmung auf Hämoglobingehalt und Erythrozytenzahl
des menschlichen Blutes. II.
Z Exp Med.
1939;
104
417-422
- 2
Anthony A J, Biedenkopf H.
Der Einfluß kurzdauernder Sauerstoffatmung auf Hämoglobingehalt und Erythrozytenzahl
des menschlichen Blutes I.
Z Exp Med.
1938;
103
451-457
- 3
Celsing F, Svedenhag J, Pihlstedt P, Ekblom B.
Effects of anaemia and stepwise induced polycythaemia on maximal aerobic power in
individuals with high and low haemoglobin concentrations.
Acta Physiol Scand.
1987;
129
47-54
- 4
Böning D, Schweigart U, Kunze M.
Diurnal variations of protein and electrolyte concentrations and of acid-base status
in plasma and red cells of normal man.
Eur J Appl Physiol.
1974;
32
239-250
- 5
Dill D B, Costill D L.
Calculation of percentage changes in volumes of blood, plasma and red cells in rehydration.
J Appl Physiol.
1974;
37
247-248
- 6
Eichner E R.
Sports anemia, iron supplementation, and blood doping.
Med Sci Sports Exerc.
1992;
24
315-318
- 7
Ekblom B, Berglund B.
Effects of erythropoietin administration on maximal aerobic power.
Scand J Med Sci Sports.
1991;
1
88-93
- 8
Finsleyson D C, Dagher F J, Vandam L D.
Diurnal variations in blood volume of man.
J Surg Res.
1964;
416
286-288
- 9
Fogh-Andersen N, Eidemak I, Lokkegaard H, Levin-Nielsen S.
Changes in blood and plasma volume during treatment with recombinant human erythropoietin.
Scand J Clin Lab Invest.
1993;
214
61-65
- 10
Fricke G.
Über das Verhalten des Zellfaktors bei Arbeit.
Cardiologia.
1965;
47
25-44
- 11
Gaethgens P, Kreutz F, Albrecht K H.
Optimal hematocrit for canine skeletal muscle during rhythmic isotonic exercise.
Eur J Appl Physiol.
1979;
41
27-39
- 12
Gallaugher P, Thorarensen H, Farrell A P.
Hematocrit in oxygen transport and swimming in rainbow trout (Oncorhynchus mykiss).
.
Respir Physiol.
1995;
102
279-292
- 13
Gareau R, Audran M, Baynes R D, Duvallet A, Senecal L, Brisson G R.
Erythropoietin abuse in athletes.
Nature.
1996;
380
113
- 14
Guyton A C.
Venous return. Handbook of Physiology. Circulation. Washington, DC. Sect 2. Vol. II.
Am Phys Soc.
1963;
32
1099-1127
- 15 Halter H. Schlamm in den Adern. Der Spiegel 1991 24
- 16
Harrison M J.
The hematocrit and cerebrovascular accidents.
Presse Med.
1983;
12
3095-3097
- 17
Hoffkes H G, Ehrly A M.
Hematocrit dependent changes of muscle tissue oxygen supply in the lower limb muscle
of patients with intermittent claudication.
Vasa.
1992;
21
350-354
- 18
Kusunoki M, Kimura K, Nakamura M, Isaka Y, Yoneda S, Abe H.
Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic
cerebrovascular disease.
J Cereb Blood Flow Metab.
1981;
1
413-417
- 19
Lee S H, Heros R C, Mullan J C, Korosue K.
Optimum degree of hemodilution for brain protection in a canine model of focal cerebral
ischemia.
J Neurosurg.
1994;
80
469-475
- 20
Lundvall J, Bjerkhoel P, Quittenbaum S, Lindgren P.
Rapid plasma volume decline upon quiet standing reflects large filtration capacity
in dependent limbs.
Acta Physiol Scand.
1996;
158
161-167
- 21
Maw G J, Mackenzie I L, Taylor N A.
Redistribution of body fluids during postural manipulations.
Acta Physiol Scand.
1995;
155
157-163
- 22
Pavy-Le-Traon A, Allevard A M, Fortrat J O, Gauquelin G, Guell A, Bes A, Gharib C.
Cardiovascular and hormonal changes induced by a simulation of a lunar mission.
Aviat Space Environ Med.
1997;
68
829-837
- 23
Schaffartzik W, Barton E D, Poole D C, Tsukimoto K, Hogan M C, Bebout D D, Wagner P D.
Effect of reduced hemoglobin concentration on leg oxygen uptake during maximal exercise
in human.
J Appl Physiol.
1993;
75
491-498
- 24 Schmidt W, Bohnsack M, Maassen N, Winchenbach P, Biermann B, Zapf J.
Physiological variations of hemoglobin concentration and hemoglobin mass in athletes.
Abstracts 26th FIMS World Congress of Sports Medicine. 30.5. - 3.6.1998. Orlando; 1998: 42
- 25
Schmidt W, Brabant G, Kröger C, Hilgendorf A, Strauch S.
Atrial natriuretic peptide during and after maximal and submaximal exercise under
normoxic and hypoxic conditions.
Eur J Appl Physiol.
1990;
61
398-407
- 26
Schmidt W, Bub A, Meyer M, Weiß T, Schneider G, Maassen N, Forssmann W G.
Is urodilatin the missing link in exercise-dependent renal sodium retention?.
J Appl Physiol.
1998;
84
123-128
- 27 Schmidt W, Weiglein K, Himmelsbach-Wegner B, Böning D.
Gesamtkörperhämoglobinmenge, Zinkprotoporphyrin und Transferrinrezeptor - Neue Marker
in der Eisendiagnostik bei Ausdauersportlerinnen?. In: Jeschke D, Lorenz R (eds) Sportartspezifische Leistungsdiagnostik - Energetische
Aspekte. Köln; Sport und Buch - Strauß 1998: 353-361
- 28
Tu Y K, Kuo M F, Liu H M.
Cerebral oxygen transport and metabolism during graded isovolemic hemodilution in
experimental global ischemia.
J Neurol Sci.
1997;
150
115-122
- 29
Wade J P.
Transport of oxygen to the brain in patients with elevated hematocrit values before
and after venesection.
Brain.
1983;
106
513-523
Prof. Dr. W. Schmidt
Abt. Sportmedizin/Sportphysiologie Universität Bayreuth
95440 Bayreuth
Germany
Phone: + 49 (921) 553464
Fax: + 49 (921) 553468
Email: walter.schmidt@uni-bayreuth.de